WAS
SRNE

Winch Advisory Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Winch Advisory Services’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-200
Closed -$1K – 359
2018
Q2 		$1K Buy
+200
New +$1.36K ﹤0.01% 330

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Winch Advisory Services's SRNE Position: Q3 2018 in Review

Winch Advisory Services sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2018, closing a stake of 200 shares — an estimated $1K sold.

Winch Advisory Services first reported a position in SRNE in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 97 funds tracked by Wall St. Rank hold SRNE as of Q3 2018.

  • Winch Advisory Services reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Winch Advisory Services sold 200 Sorrento Therapeutics, Inc. shares in Q3 2018, an estimated $1K.
  • Winch Advisory Services first reported a position in Sorrento Therapeutics, Inc. in Q2 2018 and held it in 1 quarter.
  • Winch Advisory Services's Sorrento Therapeutics, Inc. position peaked at $1K in Q2 2018.
  • 97 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2018.

Based on Winch Advisory Services's 13F filing for Q3 2018, filed 13 Nov 2018.